On November 16, 2015, UCAP entered into a subordinated note receivable agreement with UCI, a 48.9% owned equity method investee (See Note 7), in the amount of $5.0 million. On June 28, 2018 and November 28, 2018, UCAP entered into two new subordinated note receivable agreements with UCI in the amount of $2.5 million and $5.0 million, respectively (see Note 8).

During the years ended December 31, 2018 and 2017, NMM earned approximately $21.6 million and $17.6 million, respectively, in management fees

, of which $0.8 million and $0.4 million, remained outstanding, respectively,

from LMA, which is accounted for under the equity method based on 25% equity ownership interest held by APC (see Note 7).

During the years ended December 31, 2018 and 2017, APC paid approximately $

2.5

million and $

2.3

million, respectively, to PMIOC for provider services, which is accounted for under the equity method based on 40% equity ownership interest held by APC (see Note 7).

During the years ended December 31, 2018 and 2017, APC paid approximately $

7.0

million and $

6.1

million, respectively, to DMG for provider services, which is accounted for under the equity method based on 40% equity ownership interest held by APC (see Note 7).

During the year ended December 31, 2018 and 2017, APC paid approximately $

0.3

million, respectively, to Advance Diagnostic Surgery Center for services as a provider. Advance Diagnostic Surgery Center shares common ownership with certain board members of APC.

During the years ended December 31, 2018 and 2017, NMM paid approximately $

1.0

million to Medical Property Partners (“MPP”) for an office lease. MPP shares common ownership with certain board members of NMM (see Note 14).

During the years ended December 31, 2018 and 2017, APC paid approximately $0.2 million and $0.4 million, respectively, to Tag-2 Medical Investment Group, LLC (“Tag-2”) for an office lease. Tag-2 shares common ownership with a board member of APC (see Note 14).

During the years ended December 31, 2018 and 2017, the Company paid approximately $0.4 million and $0.1 million, respectively, to Critical Quality Management Corp (“CQMC”) for an office lease. CQMC shares common ownership with certain board members of APC (see Note 14).

During the years ended December 31, 2018 and 2017, SCHC paid approximately $0.5 million to Numen, LLC (“Numen”) for an office lease. Numen is owned by a shareholder of APC (see Note 14).

During the years ended December 31, 2018 and 2017, APC paid approximately $

3.8

million and $

2.1

million, respectively, to AMG, Inc. for services as a provider. AMG, Inc. shares common ownership with certain board members of APC.

The Company has agreements with HSMSO, Aurion Corporation (“Aurion”), and AHMC Healthcare (“AHMC”) for services provided to the Company. One of the Company’s board members is an officer of AHMC, HSMSO and Aurion. Aurion is also partially owned by one of the Company’s board members. The following table sets forth fees incurred and income received related to AHMC, HSMSO and Aurion Corporation:

Years ended December 31,	2018			2017

AHMC – Risk pool revenue	$	68,200,000		$	42,600,000
HSMSO – Management fees, net		(2,600,000	)		(2,600,000	)
Aurion – Management fees		(317,000	)		(284,000	)

Receipts, Net	$	65,283,000		$	39,716,000

The Company and AHMC has a risk sharing agreement with certain AHMC hospitals to share the surplus and deficits of each of the hospital pools. During the years ended December 31, 2018 and 2017 the Company has recognized risk pool revenue under this agreement of $68.2 million and $42.6 million respectively, of which $44.2 million and $12.1 million, respectively, remain outstanding as of December 31, 2018 and 2017, respectively.

During the years ended December 31, 2018 and 2017, APC paid an aggregate of approximately $

35.2

million and $

41.5

million, respectively, to shareholders of APC for provider services, which included approximately $

13.5

million and $

14.1

million, respectively, to shareholders who are also officers of APC.

In addition, affiliates wholly-owned by the Company’s officers, including Dr. Lam and Dr. Hosseinion, are reported in the accompanying consolidated statements of income on a consolidated basis, together with the Company’s subsidiaries, and therefore, the Company does not separately disclose transactions between such affiliates and the Company’s subsidiaries as related party transactions.

For equity method investments, loans receivable and line of credits from related parties, see Notes 7, 8 and 11, respectively.